These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21907684)

  • 1. Re: Testosterone therapy in men with untreated prostate cancer. A. Morgentaler, L. I. Lipshultz, R. Bennett, M. Sweeney, D. Avila, Jr. and M. Khera. J Urol 2011; 185: 1256-1261.
    Friedman AE
    J Urol; 2011 Oct; 186(4):1559; author reply 1560. PubMed ID: 21907684
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone therapy in men with untreated prostate cancer.
    Morgentaler A; Lipshultz LI; Bennett R; Sweeney M; Avila D; Khera M
    J Urol; 2011 Apr; 185(4):1256-60. PubMed ID: 21334649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment.
    Agarwal PK
    J Urol; 2011 Apr; 185(4):1261. PubMed ID: 21334657
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Miner MM
    J Urol; 2011 Apr; 185(4):1261. PubMed ID: 21334686
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone Therapy in Men With Prostate Cancer.
    Kaplan AL; Hu JC; Morgentaler A; Mulhall JP; Schulman CC; Montorsi F
    Eur Urol; 2016 May; 69(5):894-903. PubMed ID: 26719015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23.
    Klap J; Loughlin KR
    Eur Urol; 2014 Aug; 66(2):e31-2. PubMed ID: 24830626
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23.
    Khera M; Morgentaler A
    Eur Urol; 2014 Aug; 66(2):e33. PubMed ID: 24836155
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Seftel AD
    J Urol; 2015 Jun; 193(6):1985-6. PubMed ID: 25986797
    [No Abstract]   [Full Text] [Related]  

  • 9. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
    Morales A; Black AM; Emerson LE
    BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual dysfunction or infertility.
    Kacker R; Conners W; Zade J; Morgentaler A
    J Urol; 2014 Apr; 191(4):1072-6. PubMed ID: 24161998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial Clinical Experience With Testosterone Undecanoate Therapy (AVEED) in Men With Testosterone Deficiency in the United States.
    Krakowsky Y; Conners W; Davidson E; Rawji A; Morgentaler A
    Urology; 2017 Nov; 109():27-31. PubMed ID: 28735014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
    Algarté-Génin M; Cussenot O; Costa P
    Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of testosterone in men with prostate cancer and suggestions for an international registry.
    Morales A
    BJU Int; 2011 May; 107(9):1343-4. PubMed ID: 21518226
    [No Abstract]   [Full Text] [Related]  

  • 14. Testosterone replacement therapy in prostate cancer patients: is it safe?
    Umbas R; Sugiono M
    Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies and Advances With Testosterone Therapy: A 40-Year Perspective.
    Morgentaler A
    Urology; 2016 Mar; 89():27-32. PubMed ID: 26683750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone therapy in men with prostate cancer: scientific and ethical considerations.
    Morgentaler A
    J Urol; 2009 Mar; 181(3):972-9. PubMed ID: 19150547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The History of Testosterone and the Evolution of its Therapeutic Potential.
    Morgentaler A; Traish A
    Sex Med Rev; 2020 Apr; 8(2):286-296. PubMed ID: 29661690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Androgen deficiency in males and its correction in respect to pathogenesis of prostatic cancer].
    Mazo EB; Grigor'ev ME; Konorev VA; Ermisheva OM
    Urologiia; 2008; (3):57-8, 60-2. PubMed ID: 18669351
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.
    Morales A
    BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Pro.
    Morgentaler A
    J Urol; 2016 Oct; 196(4):985-8. PubMed ID: 27449261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.